Skip to content

The Value of Noninvasive test to Predicting Risk of Esophageal Varices in Patients with Hepatitis B Cirrhosis

The Value of Noninvasive test to Predicting Risk of Esophageal Varices in Patients with Hepatitis B Cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017867
Enrollment
Unknown
Registered
2018-08-18
Start date
2018-08-19
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis

Interventions

Gold Standard:endoscopy examine
Image&#32

Sponsors

Department of Ultrasound, China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with hepatitis B cirrhosis have complete clinical data and are able to undergo gastroscope and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with cirrhosis caused by other causes; 2. Patients with portal venous thrombosis, thrombocytopenia, family history of thrombocytopenia or splenic infarction, and liver cirrhosis with hepatocellular carcinoma; 3. Patients with a recent history of gastrointestinal bleeding (less than 15 days); 4. Has history of portal hypertension treatment; 5. Patients who cannot tolerate endoscopic examination; 6. The interval between ARFI examination and endoscopic examination more than 3 months; 7. ARFI failed or unreliable measurement; 8. The patient has right heart failure, abnormal bone marrow hyperplasia, blood system or autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
SWV;Ultrasound parameter;CDFI;

Countries

China

Contacts

Public ContactChunxiang Jin

Department of Ultrasound, China-Japan Union Hospital of Jilin University

jinchunxiang722@163.com+86 15943051272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026